Galena Biopharma Announces Public Offering of Common Stock
Galena Biopharma (Nasdaq: GALE) announced today that it intends to offer shares of its common stock in an underwritten public offering. Roth Capital Partners, LLC is acting as the sole book-running manager for the offering.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.